Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis

BACKGROUND: Despite toxic side effects and limited durable response, the current standard-of-care treatment for high grade serous ovarian cancer (HGSOC) remains platinum/taxane-based chemotherapy. Given that the overall prognosis has not improved drastically over the past several decades, there is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Karagoz, Kubra, Mehta, Gaurav A., Khella, Christen A., Khanna, Pooja, Gatza, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921307/
https://www.ncbi.nlm.nih.gov/pubmed/31767542
http://dx.doi.org/10.1016/j.ebiom.2019.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921307/
https://www.ncbi.nlm.nih.gov/pubmed/31767542
http://dx.doi.org/10.1016/j.ebiom.2019.11.009

Ejemplares similares